Secondly, we showed that the density of the lipid raft protein MAL (and potentially MAL2) is augmented in light-density sucrose gradient fractions from human SAECs challenged with pEVs from COVID-19 patients compared to those from non-COVID-19 patients. This evidence concerns the gene MAL2 and COVID-19.